If you have been reading about angiotensin IV and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2025-09-24. Numbers and descriptions here follow the published literature rather than marketing material.
The angiotensin IV connection places dihexa in a family of short peptides studied for effects on central nervous system signaling. Angiotensin IV itself is a metabolite of angiotensin II, and analogs have been explored in cardiovascular and neurological research. Dihexa differs from the natural peptide through structural modifications intended to alter stability and receptor interactions. Published descriptions sometimes call it a hepatocyte growth factor mimetic, although that label reflects proposed activity rather than a confirmed clinical mechanism.
Identity checks for dihexa usually rely on mass spectrometry and chromatographic purity analysis. A lyophilized powder is the common supplied form, and it may appear as a white to off-white solid. Aqueous solubility is limited, so laboratory work often uses an organic solvent such as dimethyl sulfoxide to prepare stock solutions. Because the peptide is not a standard pharmaceutical product, exact specifications can vary between suppliers. Certificates of analysis may accompany a batch, but they are not equivalent to regulatory approval.
Dihexa is a synthetic peptide with the chemical name N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide, and it is structurally related to angiotensin IV, a naturally occurring peptide fragment. Researchers developed it as a modified analog intended to alter stability and activity relative to the parent peptide. Its short sequence and fatty acid chain distinguish it from many endogenous peptides, and published studies often describe it under the abbreviation dihexa. The compound is classified as a laboratory compound rather than an approved therapeutic in most jurisdictions.
Early laboratory work focused on its effects on synaptic connectivity and neuronal signaling. In cell and animal models, dihexa has been reported to promote the formation of new synapses, a process called synaptogenesis. These findings have generated interest in cognitive research, but the evidence base remains mostly preclinical. Human clinical trials with clear safety and efficacy endpoints are limited or absent in the public literature. Whether these effects translate to humans is an open question.
The proposed mechanism involves interaction with the hepatocyte growth factor (HGF) system and its receptor, c-Met. Dihexa is described in some studies as an HGF mimetic, meaning it may mimic or enhance HGF-mediated signaling. Activation of c-Met can influence cell growth, survival, and cytoskeletal remodeling, pathways that intersect with synaptic plasticity. However, the precise binding targets and downstream events for dihexa are not fully established, and alternative mechanisms have been suggested.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic peptide analog | Modeled on angiotensin IV; not a natural hormone. |
| Common synonyms | Dihexa; N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide | Naming conventions differ across vendors and papers. |
| CAS Registry Number | 1401708-83-6 | Listed in some chemical databases; verify against primary sources. |
| Appearance | White to off-white powder | Typical form for lyophilized research peptides. |
| Solubility | Soluble in DMSO; limited in water | Organic stock solutions are common in laboratory settings. |
Most published work on dihexa consists of preclinical studies using cell cultures or rodents. Reports have described effects on synaptic connectivity and performance on cognitive tasks in some animal models. These findings are generally presented as preliminary and require independent replication. Study designs, doses, and outcome measures vary across experiments, which complicates direct comparison. No large controlled human trials have established efficacy or safety for any medical use. At present, the evidence base is limited.
Regulatory agencies have not approved dihexa as a prescription drug or supplement. In many countries it falls into a gray area when sold for laboratory research. Buyers may encounter products marketed for research use only, which are not intended for human consumption. Purity and identity can vary between suppliers and batches. Certificates of analysis and independent testing are often recommended for research materials. Documentation helps verify what a vial contains.
Discussion of dihexa in online communities sometimes outpaces the scientific record. Anecdotal reports are difficult to verify and may not distinguish effects from placebo or expectation. The absence of approved human data means long-term risks remain unknown. Researchers continue to investigate related compounds and pathways. Open questions include whether animal findings translate to humans and which biological targets matter most. No consensus exists on these points. Current reviews emphasize the need for rigorous clinical research.
Dihexa is a synthetic peptide derived from angiotensin IV, a naturally occurring fragment of the renin-angiotensin system. Researchers modified the angiotensin IV structure to improve metabolic stability and central nervous system activity. It is frequently described as a hepatocyte growth factor mimetic because it can activate the c-Met receptor pathway in experimental systems. Its development reflects interest in small peptides that influence synaptic plasticity and cognitive processes. Most information comes from preclinical studies rather than controlled human trials.
The compound has been examined in animal models for effects on learning, memory, and synaptic connectivity. Some reports describe increased dendritic spine density and improved performance on certain behavioral tasks after administration in rodents. These findings are often cited in discussions of nootropic research peptides, but replication across independent laboratories remains limited. The absence of published phase 1 or phase 2 clinical trial data makes it difficult to assess safety, effective routes, or long-term outcomes in humans. Consequently, claims about cognitive benefits in people remain speculative.
An alcohol treated with at least 3 equivalents of an activated halide (such as allyl bromide or iodomethane) and CDI yields the corresponding halide with good yield. Bromination and iodination work best, though this reaction does not preserve the stereochemistry of the alcohol. In a similar context, CDI is often used in dehydration reactions. As CDI is an equivalent of phosgene, it can be used in similar reaction, however, with increased selectivity: it allows the synthesis of asymmetric bis alkyl carbonates
SSRIs can also induce apoptosis, programmed cell death, in T-cells. The full mechanism of action for the anti-inflammatory effects of SSRIs is not fully known. However, there is evidence for various pathways to have a hand in the mechanism. One such possible mechanism is the increased levels of cyclic adenosine monophosphate (cAMP) as a result of interference with activation of protein kinase A (PKA), a cAMP-dependent protein. Other possible pathways include interference with calcium ion channels, or inducing cell death pathways like MAPK and Notch signaling pathway. The anti-inflammatory effects of SSRIs have prompted studies of the efficacy of SSRIs in the treatment of autoimmune diseases such as multiple sclerosis, RA, inflammatory bowel diseases, and septic shock. These studies have been performed in animal models but have shown consistent immune regulatory effects. Fluoxetine, an SSRI, has also shown efficacy in animal models of graft vs. host disease. SSRIs have also been used successfully as pain relievers in patients undergoing oncology treatment. The effectiveness of this has been hypothesized to be at least in part due to the anti-inflammatory effects of SSRIs.
In 2015, Duterte made homophobic remarks about United States ambassador Philipp Goldberg after Secretary of State John Kerry visited the Philippines. Duterte's record on human rights and his long history of comments that have widely been considered to be offensive, provocative, threatening, and undiplomatic have received sharp international criticism. He has been portrayed by his critics in the media as having a "dirty mouth". He had, however, promised to behave in a "prim and proper" manner on the national and international stage once he was to be inaugurated as president, to the point that, "almost, I would become holy." Throughout his presidency, Duterte has made controversial comments about rape, human rights, his views on media killings, and has used slurs; he has also made controversial statements to international leaders and institutions. He has also repeatedly criticized the Catholic Church which has expressed alarm over deaths linked to the war on drugs. Human Rights Watch (HRW) called the first year of Duterte in office a "human rights calamity". HRW estimates that there have been 7,000 deaths from the day Duterte first took office to January 2017. The Duterte administration suspended the drug war in February 2017 in an effort to cleanse the police ranks of supposed corruption, also halting the disclosure of figures on deaths related to drug arrests and raids. In March 2017, HRW released a special investigation and report on the state of police related shooting, titled "License To Kill".
Sources: en.wikipedia.org
=== Non-ruminants === Rats that were given a diet containing ptaquiloside for a prolonged period developed tumors in both the ileum and urinary bladder. Prakash, Smith and co-workers showed that ptaquiloside-induced carcinogenesis was initiated by the activation of the H-ras oncogene. Other non-ruminants such as pig, rabbit, and guinea pig, also develop syndromes after ingestion of ptaquiloside, which include haematuria, tumors and organ abnormities (see the diagram).
Westbrook* (1968), writer, son of syndicated columnist Sheilah Graham Westbrook Phillip Lopate (1964), essayist and fiction writer Ron Padgett (1964), poet and translator, winner of the Shelley Memorial Award in 2009 and Robert Frost Medal in 2018 Steven Millhauser (1965), novelist and winner of the Pulitzer Prize for Fiction for Martin Dressler: The Tale of an American Dreamer Aaron Fogel (1967), poet Eric Van Lustbader (1967), espionage and thriller novelist, writer of Jason Bourne novels Thomas Hauser (1968), author of nonfiction and biographer David Shapiro (1968), poet, literary critic, professor at William Paterson University Hilton Obenzinger (1969), novelist, poet, history and criticism writer Paul Auster (1970), postmodern writer; author of The New York Trilogy, Moon Palace, and the Brooklyn Follies Bob Holman (1970), poet and activist identified with the oral tradition David Lehman (1970), poet, editor of The Best American Poetry series Joshua Rubenstein (1971), writer, winner of a National Jewish Book Award in 2002 Alex Abella (1972), Cuban-American writer Brad Gooch (1973), writer, professor of English at William Paterson University John Prados (1973), author and historian on World War II and the Cold War Todd McEwen (1975), writer, professor at the University of Kent Stephen O'Connor (1975), writer and professor at Sarah Lawrence College Damien Bona (1977), chronicler of the Academy Awards Mason Wiley (1977), co-author of The Official Preppy Handbook Kevin Baker (1980), novelist and freelance journalist Jeffrey Harrison (1980), poet who won the 1988 Amy Lowell Poetry Travelling Scholarship Lou Antonelli (1981), science fiction writer Douglas Sadownick (1981), writer and psychologist Michael Friedman (1982), novelist and author Michael Azerrad (1983), author, journalist, musician Thomas Dyja (1984), writer, historian, winner of the 1997 Casey Award David Rakoff (1986), comedic essayist Louise Wareham Leonard (1987), writer Al Weisel (1987), freelance writer Adrienne Brodeur (1988), author, program director at Aspen Institute Glen Hirshberg (1988), author, recipient of the 2007 Shirley Jackson Award Adam Mansbach (1988), author and former professor of literature at Rutgers University–Camden Darryl Pinckney (1988), novelist, playwright, and essayist Mako Yoshikawa (1988), novelist, professor at Emerson College Ben Coes (1989), author of political thriller and espionage novels Wade Graham (1989), author, historian, environmentalist G. Winston James (1989), poet, author, activist Robert Salkowitz (1989), author on technology innovation Carol Guess (1990), novelist and poet; professor at Western Washington University John Reed (1990), novelist; author of Snowball's Chance David S. Levinson (1991), short-story writer and novelist Robert Kolker (1991), writer, author of Hidden Valley Road Kelly Link (1991), Hugo Award-winning author; founder of Small Beer Press; editor of St. Martin's Press's Year's Best Fantasy and Horror Loren Goodman (1991), postmodern poet, professor at Underwood International College Andrew Carroll (1992), author, editor, activist, and historian Jordan Davis (1992), poet John Bemelmans Marciano (1992), children's book author and illustrator, grandson of Ludwig Bemelmans, author of Madeline Marie Mutsuki Mockett (1992), writer Melissa de la Cruz (1993), writer known for work in young adult fiction Jay Michaelson (1993), writer and LGBTQ activist Maxine Swann (1994), fiction writer Robert Westfield (1994), writer who won two Lambda Literary Awards Megan McCafferty (1995), chick lit writer, Jessica Darling series, which were plagiarized by Kaavya Viswanathan Tova Mirvis (1995), author Saleemah Abdul-Ghafur (1996), author and Islamic activist Fredrik Stanton (1996), author of Great Negotiations and former publisher for the Columbia Daily Spectator Aravind Adiga (1997), Man Booker Prize-winning novelist Jamel Brinkley (1997), author, winner of the 2018 Ernest J. Gaines Award for Literary Excellence John Coletti (1997), author Gotham Chopra (1997), author, son of health advocate Deepak Chopra Lauren Grodstein (1997), author, professor of Rutgers University–Camden Abdi Nazemian (1998), Iranian-American author, winner of the 2017 Lambda Literary Award for Debut Fiction Trevor Shane (1998), writer Daniel Alarcón (1999), novelist Katherine Howe (1999), novelist, author of The Physick Book of Deliverance Dane Rebecca Pawel (1999), author of mystery novels; winner of the 2004 Edgar Allan Poe Award for Best First Novel Alex Marzano-Lesnevich (2001), author, winner of a 2018 Lambda Literary Award and Chautauqua Prize Fiona Sze-Lorrain (2003), French writer, poet, translator, musician Ben Dolnick (2004), writer, son of biographer Edward Dolnick, member of the Ochs-Sulzberger family that owns The New York Times Danielle Valore Evans (2004), fiction writer Adam Gidwitz (2004), author of best selling children's books Alaya Dawn Johnson (2004), author and winner of the 2015 Andre Norton Award Tongo Eisen-Martin (2004), poet laureate of San Francisco Sidik Fofana (2005), public school teacher and writer, winner of a 2023 Whiting Award Victoria Loustalot (2006), writer of memoir and essays Crystal Hana Kim (2009), writer, If You Leave Me Morgan Parker (2010), poet and Cave Canem Fellow Rachel Heng (2011), Singaporean writer Ben Philippe (2011), author, screenwriter, recipient of the 2020 William C. Morris Award Rowan Hisayo Buchanan (2012), British-American writer, recipient of the Betty Trask Award and the Authors' Club Best First Novel Award Sylvia Khoury (2012), writer and playwright, recipient of a 2021 Whiting Award Yanyi (2013), poet
US pathology firm CPL-Clinical Pathology Laboratories for $US123.5 million (A$121.5 million). In 2010, Sonic Healthcare acquired Labor Lademannbogen (Hamburg, Germany) and Medhold Group (Antwerp, Belgium), and through the IPN the Prime Health Group. In the US, the company acquired CBLPath (Rye Brook, NY) and Physician's Automated Laboratory (Bakersfield, California).
Sources: en.wikipedia.org
The expectation to experience rejection can become an important stressor for transgender and gender non-conforming individuals. Mental health problems among trans people are related to higher rates of self-harm, drug usage, and suicidal ideations and attempts.
=== Diagnosis === In 2010, a team from New York described detection of PrPSc in sheep's blood, even when initially present at only one part in one hundred billion (10−11) in sheep's brain tissue. The method combines amplification with a novel technology called surround optical fiber immunoassay (SOFIA) and some specific antibodies against PrPSc. The technique allowed improved detection and testing time for PrPSc. In 2014, a human study showed a nasal brushing method that can accurately detect PrP in the olfactory epithelial cells of people with CJD.
Amino acid N-carboxyanhydrides, also called Leuchs' anhydrides, are a family of heterocyclic organic compounds derived from amino acids. They are white, moisture-reactive solids. They have been evaluated for applications the field of biomaterials.
Sources: en.wikipedia.org
Dihexa is a synthetic peptide analog related to angiotensin IV. It is studied in preclinical research for effects on neural signaling and synapse formation. It is not an approved medicine.
No. Dihexa shares a conceptual link to angiotensin IV but has different structural features. Those changes are intended to modify its behavior in biological systems.
It often appears as N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide. Synonyms and CAS listings vary, so cross-checking identifiers is necessary.
Dihexa is a synthetic peptide analog of angiotensin IV, often described as an HGF mimetic in research literature. It is studied for effects on synaptic connectivity in laboratory models. It is not an approved medication.